Beware of Scam Using Our Company Name for Fake Job Interviews
Beware of Scam Using Our Company Name for Fake Job Interviews
Dear Valued Partners and Friends,
We hope this message finds you well. We have recently become aware of a scam involving Scailyte’s name and information, which we feel is crucial to bring to your attention.
The scammers are using our brand name to trick people into downloading a chat app with the promise of a job interview. They impersonate our HR representatives and engage in fake interviews, often asking for sensitive personal information or money in the name of a job offer.
Please be aware that we have not authorized any third-party apps or services to conduct job interviews on our behalf. All our official job postings can be found on our website, and we only use authorized communication channels for our recruitment process.
To protect yourself from this scam, please follow these guidelines:
Always verify the source of any job offers or interview invitations, and ensure they come directly from our official channels.
Never download any unknown apps or software, particularly if you receive unsolicited requests to do so.
Never provide personal or financial information to anyone claiming to represent our company without verifying their identity.
If you encounter any suspicious activities, please report them to us immediately at contact@scailyte.com.
Report your fraud, scams and bad business practices at https://reportfraud.ftc.gov/
We apologize for any confusion or inconvenience this may have caused and thank you for your continued trust in our brand. We are working closely with the appropriate authorities to address this.
Best regards,
Peter Nestorov, CEO
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
Precision Medicine and The Future of Genomics Summit 2024
Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...
Recent News
Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution
In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...
Recent News
Recent News
Pitch Nic 2024 at Novartis Campus
We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...
Recent News
Genomics for Health 2024
Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...
Recent News
The Year of the AI Nobel
2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...
Recent News
Life Science Industry Meets Data Science Symposium
Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...
Recent News
World CB & CDx Summit 2024
Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...
Recent News
Precision Medicine and The Future of Genomics Summit 2024
Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...
Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution
In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...
Recent News
Pitch Nic 2024 at Novartis Campus
We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...
Recent News
Genomics for Health 2024
Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...
The Year of the AI Nobel
2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...
Recent News
Life Science Industry Meets Data Science Symposium
Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...
World CB & CDx Summit 2024
Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...